Literature DB >> 25119013

Primary mucinous cystadenocarcinoma of the breast with amplification of the HER2 gene confirmed by FISH - case report and review of the literature.

Betul Bolat Kucukzeybek1, Seyran Yigit, Ayşegul Akder Sari, Turkan Rezanko, Evren Durak, Canan Sadullahoglu.   

Abstract

Fifty five-years-old woman was presented to the general surgery upon the palpation of a mass in her left breast. In the excisional biopsy performed, partially cystic tumor of 2 × 1 cm with solid areas was macroscopically observed. After through microscopic examination, the patient was diagnosed as invasive mucinous cystadenocarcinoma and the tumor was found to be ER- and PR-negative and C-erbB2 (2+). In the fluorescent in situ hybridization, HER2/neu gene amplification was observed. Here, we present the clinical, cytological, morphological and immunohistochemical features of a very rare type of breast carcinoma, mucinous cystadenocarcinoma of the breast, with the review of the relevant literature.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25119013     DOI: 10.5114/pjp.2014.42673

Source DB:  PubMed          Journal:  Pol J Pathol        ISSN: 1233-9687            Impact factor:   1.072


  4 in total

1.  Mucinous breast carcinoma with tall columnar cells.

Authors:  N Tsoukalas; M Kiakou; M Tolia; I D Kostakis; M Galanopoulos; G Nakos; D Tryfonopoulos; G Kyrgias; G Koumakis
Journal:  Ann R Coll Surg Engl       Date:  2018-04-16       Impact factor: 1.891

2.  Mucinous cystadenocarcinoma of the breast: a new entity with broad differentials-a case report.

Authors:  Kanwalpreet Kaur; Ashini Shah; Jahnvi Gandhi; Priti Trivedi
Journal:  J Egypt Natl Canc Inst       Date:  2022-02-28

Review 3.  Rare Breast Cancer Subtypes.

Authors:  Sarah Jenkins; Megan E Kachur; Kamil Rechache; Justin M Wells; Stanley Lipkowitz
Journal:  Curr Oncol Rep       Date:  2021-03-23       Impact factor: 5.075

4.  Mucinous cystadenocarcinoma of the breast: the challenge of diagnosing a rare entity.

Authors:  Nektarios Koufopoulos; Christina Goudeli; John Syrios; Evangelos Filopoulos; Lubna Khaldi
Journal:  Rare Tumors       Date:  2017-10-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.